X
Email:
sales@ruixibiotech.com

Bi2S3-CeO2-phenylanine nanoparticles

Phenylalanine modified CeO2-Bi2S3 nanomaterials

Catalog # Pkg Size Price(USD) Quantity Buy this product
R-M2c-9671 200mg 1149.00
- +
+ Add to cart
R-M2c-9671 500mg 2399.00
- +
+ Add to cart

Product description

The hybrid nanoparticles may find application as contrast agents in imaging techniques like MRI or fluorescence imaging due to potential of phenylalanine interaction with biological systems.Phenylalanine can aid in targeting specific cells or tissues, making the nanoparticles suitable for drug delivery applications.These nanoparticles could be utilized in biosensors or diagnostic tools due to their biocompatible nature and potential for specific molecular recognition.

The integration of Bi2S3-CeO2-phenylanine nanoparticles/Phenylalanine modified CeO2-Bi2S3 nanomaterials opens up exciting prospects for biomedical applications, combining the strengths of inorganic materials with biological components. These hybrid nanoparticles have the potential to revolutionize areas such as drug delivery, imaging, and biosensing, offering tailored solutions for various biomedical challenges. 


Appearance N/A
Size 50-100nm
Solubility N/A
Is there a core-shell structure, embedded structure, or uniform distribution between cerium oxide and bismuth sulfide? Uniform distribution can be observed by TEM
What is the density of phenylalanine modification on the surface? Cannot calculate density of phenylalanine modification
Quality ratio to CeO2: Bi2S3: Phenylalanine=? The proportion is only approximate: 100:75:28, and the mass fraction of phenylalanine surface modified is 12% -16%
Is the synthesized composite nanomaterial porous? Microporous structure
Storage 4℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 3 weeks
Stability 6 months
Document

Related Product